One platform connecting startups, corporations, research institutions, regions and investors
Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
EDTECH: LEVERAGING AI-POWERED TECHNOLOGIES TO TRANSFORM THE LEARNING EXPERIENCE
1. Technology overview
Optomed is a Finnish medtech company and a major provider of handheld fundus cameras, developing AI-powered screening for earlier detection of disease. Its products are sold in over 60 countries.
Optomed Lumo is its flagship handheld fundus camera, positioned as an AI integration platform. In January 2026 it was approved for integration with Aireen's diabetic retinopathy algorithm (CE-marked MDR Class IIb), enabling a commercial launch across Europe. Aurora AEYE pairs the Aurora camera with FDA-cleared autonomous DR AI in the United States.
2. Highlighted features & specifications
- Optomed Lumo: Flagship handheld fundus camera with AI integration.
- Aireen DR AI: Automated detection and grading of diabetic retinopathy.
- Aurora AEYE: Autonomous DR AI with FDA clearance for the Aurora camera.
- System connectivity: Works with PACS, HIS and other healthcare platforms via the AI partner.
- Broader portfolio: Handheld and desktop cameras plus radiology and cancer screening products.
3. Potential application
Provincial diabetes clinics in Vietnam can run handheld retinal screening during routine visits. Mobile eye-care programs can screen remote communities. Optical retail and health-check chains can add retinal imaging services.
4. Benefits
Handheld camera brings retinal screening to primary care and outreach without a fixed imaging room.
CE-marked DR algorithm integration reduces the need for specialist grading.
Aireen's algorithm reports 94.8% sensitivity and 91.4% specificity with Optomed handheld imaging (release figure, measured on Aurora).
Camera hardware holds CE, FDA and CFDA approvals.
5. Market trends & opportunities
Handheld fundus cameras with AI are spreading as diabetic eye screening moves into primary care. Vietnam and Southeast Asia face a large diabetic population and limited retina specialists, so portable camera-plus-AI bundles suit provincial hospitals.
6. Other information
Finnish medtech company; products sold in 60+ countries. Aireen integration for Optomed Lumo approved January 2026. Camera approvals include CE, FDA and CFDA. IAPB Valued Supplier status and EcoVadis Committed Badge.
